Clinical Diagnostics in Patients with Cerebral Infarction Due To Covid-19

Authors

  • Jumraini Tammasse
  • Muhammad Iqbal Basri
  • Muhammad Akbar

DOI:

https://doi.org/10.37506/ijfmt.v15i2.15034

Keywords:

Diagnostics, Cerebral infarction, Corona Virus Disease 19 (COVID-19)

Abstract

The Corona Virus Disease 19 (COVID-19) outbreak is a deadly disease of concern to the world, including
Indonesia. Reported cases of death show a high number with more than 3800 deaths reported. This disease
can induce Cytokine Storm Syndrome (CSS) and interfere with the Blood-Brain Barrier (BBB), causing
coagulopathy and hypoxia, which in turn lead to cerebral edema in the brain. This research uses a case
study approach, with a detailed examination of one event. In this case, cerebral infarction was caused by
COVID-19 as evidenced by laboratory results in the presence of symptoms of inflammation, CSF, sepsis,
and coagulopathy. These symptoms can result in cerebral infarction and hypercoagulability. therapeutic
interventions are carried out in reducing inflammation, reducing cerebral edema, and preventing secondary
infection. COVID-19 in this case can have a deleterious effect on patients with cerebral infarction. Proper
treatment is needed to give better results.

Author Biographies

Jumraini Tammasse

Lecture Department of Neurology, Faculty of Medicine in Hasanuddin University, Makassar, Indonesia

Muhammad Iqbal Basri

Lecture Department of Neurology, Faculty of Medicine in Hasanuddin University, Makassar, Indonesia

Muhammad Akbar

Lecture Department of Neurology, Faculty of Medicine in Hasanuddin University, Makassar, Indonesia

Published

2021-03-24

How to Cite

Jumraini Tammasse, Muhammad Iqbal Basri, & Muhammad Akbar. (2021). Clinical Diagnostics in Patients with Cerebral Infarction Due To Covid-19. Indian Journal of Forensic Medicine & Toxicology, 15(2), 4221-4223. https://doi.org/10.37506/ijfmt.v15i2.15034